全文获取类型
收费全文 | 2230篇 |
免费 | 227篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 91篇 |
妇产科学 | 46篇 |
基础医学 | 380篇 |
口腔科学 | 52篇 |
临床医学 | 289篇 |
内科学 | 431篇 |
皮肤病学 | 16篇 |
神经病学 | 206篇 |
特种医学 | 255篇 |
外科学 | 235篇 |
综合类 | 35篇 |
一般理论 | 2篇 |
预防医学 | 102篇 |
眼科学 | 35篇 |
药学 | 151篇 |
中国医学 | 6篇 |
肿瘤学 | 117篇 |
出版年
2023年 | 12篇 |
2022年 | 21篇 |
2021年 | 44篇 |
2020年 | 25篇 |
2019年 | 29篇 |
2018年 | 44篇 |
2017年 | 31篇 |
2016年 | 34篇 |
2015年 | 44篇 |
2014年 | 47篇 |
2013年 | 53篇 |
2012年 | 87篇 |
2011年 | 93篇 |
2010年 | 74篇 |
2009年 | 87篇 |
2008年 | 93篇 |
2007年 | 76篇 |
2006年 | 89篇 |
2005年 | 61篇 |
2004年 | 57篇 |
2003年 | 67篇 |
2002年 | 63篇 |
2001年 | 65篇 |
2000年 | 65篇 |
1999年 | 57篇 |
1998年 | 68篇 |
1997年 | 67篇 |
1996年 | 75篇 |
1995年 | 56篇 |
1994年 | 58篇 |
1993年 | 61篇 |
1992年 | 39篇 |
1991年 | 32篇 |
1990年 | 50篇 |
1989年 | 58篇 |
1988年 | 46篇 |
1987年 | 50篇 |
1986年 | 52篇 |
1985年 | 51篇 |
1984年 | 28篇 |
1983年 | 25篇 |
1982年 | 31篇 |
1981年 | 22篇 |
1980年 | 14篇 |
1979年 | 23篇 |
1978年 | 15篇 |
1977年 | 25篇 |
1976年 | 26篇 |
1975年 | 24篇 |
1974年 | 17篇 |
排序方式: 共有2465条查询结果,搜索用时 15 毫秒
1.
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
4.
Leo Sher Juan J Carballo Michael F Grunebaum Ainsley K Burke Gil Zalsman Yung-yu Huang J John Mann Maria A Oquendo 《Bipolar disorders》2006,8(5P2):543-550
Objectives: Bipolar disorder is a severe illness that is associated with suicidal behavior. A biological predictor of highly lethal suicide attempts in patients with bipolar disorder would be valuable. We hypothesized that cerebrospinal fluid (CSF) monoamine metabolite levels are related to lethality of suicide attempts in bipolar patients and examined the relation between CSF 5-hydroxyindolacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) levels and maximum lethality of suicide attempts at baseline and during a 2-year follow up.
Methods: Twenty-seven bipolar depressed patients participated in the study. Demographic and clinical parameters were examined and recorded. Lumbar punctures were performed and CSF 5-HIAA, HVA, and MHPG were assayed by high-performance liquid chromatography with electrochemical detection. Following discharge, patients were evaluated after 3 months, 1 year, and 2 years. Each follow-up interview included an in-depth assessment of suicidal behavior during the intervening time period.
Results: Six subjects made suicide attempts during the 2-year follow-up. Bipolar patients who attempted suicide during the follow-up period had higher aggression and hostility scale scores compared to bipolar subjects who did not make a suicide attempt during the follow-up period. CSF 5-HIAA, HVA, and MHPG levels were negatively correlated with the maximum lethality of suicide attempts during the 2-year follow-up period.
Conclusions: Our finding is the first observation that CSF monoamine metabolite levels may be predictors of lethality of suicide attempts in patients with bipolar disorder. Further studies are necessary to answer the question whether CSF monoamine metabolite levels are clinically useful biochemical predictors of highly lethal suicide attempts or completed suicides. 相似文献
Methods: Twenty-seven bipolar depressed patients participated in the study. Demographic and clinical parameters were examined and recorded. Lumbar punctures were performed and CSF 5-HIAA, HVA, and MHPG were assayed by high-performance liquid chromatography with electrochemical detection. Following discharge, patients were evaluated after 3 months, 1 year, and 2 years. Each follow-up interview included an in-depth assessment of suicidal behavior during the intervening time period.
Results: Six subjects made suicide attempts during the 2-year follow-up. Bipolar patients who attempted suicide during the follow-up period had higher aggression and hostility scale scores compared to bipolar subjects who did not make a suicide attempt during the follow-up period. CSF 5-HIAA, HVA, and MHPG levels were negatively correlated with the maximum lethality of suicide attempts during the 2-year follow-up period.
Conclusions: Our finding is the first observation that CSF monoamine metabolite levels may be predictors of lethality of suicide attempts in patients with bipolar disorder. Further studies are necessary to answer the question whether CSF monoamine metabolite levels are clinically useful biochemical predictors of highly lethal suicide attempts or completed suicides. 相似文献
5.
6.
7.
8.
9.
10.